Merck Global Health Innovation Fund — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
HealthtechNew York, US
Kiel Dowlin(Director)Kyle Waters(Executive Officer, Director)David Stein(Executive Officer, Director)
Co-investorsXRC
Atropos Health develops a cloud-based platform that generates real-world evidence from electronic health records to inform clinical decision-making and healthcare research.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechStanford, US
Nigam Shah(Co-Founder & Chief Data Scientist)Brigham Hyde(Chief Executive Officer & co-Founder)inSaurabh Gombar(Chief Medical Officer & co-Founder)inNigam Shah, PhD MBBS(Co-Founder of Atropos Health & Chief Data Scientist at Stanford Health Care)NEIL SANGHAVI(Executive Officer)in
BoardMATTHEW BETTONVILLE(Director)
Co-investorsYosemiteBreyer CapitalCencora VenturesCerity Partners Venturesmark vcMcKesson Ventures+2 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions to help people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtech
Co-investorsAlta PartnersThreshold VenturesAlly Bridge GroupGeneral CatalystGeodesic CapitalHuman Capital+2 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Founder & CEO)in
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint VenturesHuman Capital+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.